Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma

Mohammed A Fouda1,2, David Zurakowski3, R Michael Scott4

  • 1Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA. Mfouda1@jhmi.edu.

Insights

Pediatric craniopharyngioma patients older than 10, with high BMI, or papilledema face higher risks of morbid hypothalamic obesity. A new scoring system helps predict and manage this condition.

Area of Science:

  • Pediatric Endocrinology
  • Neuro-oncology
  • Obesity Medicine

Background:

  • Craniopharyngioma is a brain tumor affecting the pituitary gland and hypothalamus.
  • Hypothalamic obesity is a serious complication following craniopharyngioma treatment.
  • Identifying risk factors and management strategies is crucial for patient outcomes.

Purpose of the Study:

  • Identify independent risk factors for morbid hypothalamic obesity in pediatric craniopharyngioma.
  • Develop a predictive scoring system for morbid hypothalamic obesity.
  • Propose a management algorithm to minimize obesity risk.

Main Methods:

  • Retrospective analysis of pediatric craniopharyngioma patients treated at Boston Children's Hospital (1985-2017).
  • Data analysis using IBM SPSS Statistics.
  • Inclusion criteria applied to 90 out of 105 diagnosed patients.

Main Results:

  • Morbid hypothalamic obesity observed in 31.1% of patients at last follow-up.
  • Independent risk factors identified: age > 10 years at diagnosis (P=0.023), preoperative BMI > 95th percentile (P=0.006), and preoperative papilledema (P<0.001).
  • Median age at diagnosis was 8.4 years; median follow-up was 10.6 years.

Conclusions:

  • Age, preoperative BMI, and papilledema are significant predictors of morbid hypothalamic obesity.
  • A novel predictive scoring system was developed to stratify risk.
  • The study provides a foundation for a management algorithm to mitigate obesity risk.
Abstract